⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Collibra Named Databricks' Governance Partner of the Year; Collibra and Databricks Deepening a Partnership to Ground Agentic AI in Governed Context
prnewswire.com
RIVN
MA
BABA
UBER
CMG
ADI
AMZN
GOOG
MSFT
NVDA
CRM
PYPL
IBM
INTC
ADBE
NFLX
HON
GE
BA
CAT
UNH
PEP
KO
MCD
COST
WMT
TMO
ABBV
XOM
CVX
JPM
BAC
WFC
C
GS
MS
DIS
CMCSA
VZ
T
SBUX
NKE
MDT
AMGN
GILD
BMY
PFE
MRK
JNJ
PG
LMT
RTX
GD
LRCX
MU
AMD
QCOM
TXN
AVGO
AMAT
KLAC
ASML
ENPH
CRSP
REGN
VRTX
BIIB
AZN
SNY
LLY
BNTX
XCUR
ALGN
TDOC
ZBRA
ROKU
UL
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
prnewswire.com
SNN
ABBV
CNXU
SYK
ESTA
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
prnewswire.com
ABBV
Listening Sets Leaders Apart at the Fortune Best Workplaces in New York, Texas, Chicago, and the Bay Area
globenewswire.com
ABBV
CSCO
NVDA
CDNS
CRM
BOX
AXP
CPT
Next Generation Drug Conjugates Market Expected to Reach USD 42.55 Billion by 2035 | MarketsandMarkets™
globenewswire.com
AZN
NVS
ALNY
GILD
ABBV
IONS
SNY
Retinal Vein Occlusion Treatment Disease Market Size Worth USD 5.28 Billion by 2035, Expanding at a 6.44% CAGR – SNS Insider
globenewswire.com
REGN
ABBV
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
prnewswire.com
ABBV
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
prnewswire.com
ABBV
Antibody Partnering Surges into 2026: Q1 Deals Top $36 Billion as Bispecifics and Discovery Platforms Drive Competition
globenewswire.com
ABBV
LLY
MRK
NVS
PFE
SNY
GILD
BMY
JNJ
UCB
Bitget 持续推进股票现货扩容，新增 30 个主流市场主题资产
globenewswire.com
ABBV
ADP
BKSY
BWXT
CAVA
CLSD
CGNX
CRSP
DIS
DUOL
HIMX
HPE
KO
LCID
LMT
ROKU